Requires registration and regulation of certain hemp-derived cannabinoids manufactured and sold in this State.

This bill (A4082) requires manufacturers and sellers of certain hemp-derived cannabinoid products - like Delta-8-THC edibles, supplements, and vape products - to register with and comply with safety regulations set by New Jersey’s Cannabis Regulatory Commission. It directly affects businesses selling these products, mandating product testing, accurate labeling of cannabinoid content, and adherence to safety standards to address concerns about high THC levels and unregulated ingredients. Key provisions include defining regulated terms (e.g., "Delta-8-THC" and "artificially derived cannabinoids"), requiring dry-weight testing for THC content, and prohibiting unsafe contaminants. The law aims to ensure product safety by bringing these currently unregulated items under the state’s existing cannabis regulatory framework.